看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Ps Multiple | 2.6x - 2.9x | 2.7x |
| Selected Fwd Ps Multiple | 2.3x - 2.5x | 2.4x |
| Fair Value | $16.37 - $18.09 | $17.23 |
| Upside | 49.1% - 64.7% | 56.9% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Sysmex Corporation | 686,900.0% | TSE:6869 |
| Terumo Corporation | 454,300.0% | TSE:4543 |
| HOYA Corporation | 774,100.0% | TSE:7741 |
| Shandong Weigao Group Medical Polymer Company Limited | 106,600.0% | SEHK:1066 |
| Abbott Laboratories | - | KAS:ABT_KZ |
| Olympus Corporation | - | OTCPK:OCPN.F |
| Select Price / LTM Sales Ratio | ||||||||
| Benchmark Companies | ||||||||
| 6869 | 4543 | 7741 | 1066 | ABT_KZ | OCPN.F | |||
| TSE:6869 | TSE:4543 | TSE:7741 | SEHK:1066 | KAS:ABT_KZ | OTCPK:OCPN.F | |||
| Historical Sales Growth | ||||||||
| 5Y CAGR | 9.5% | 9.0% | 6.2% | 4.7% | 5.6% | 3.4% | ||
| 3Y CAGR | 14.8% | 14.5% | 11.7% | -0.3% | -0.9% | 8.6% | ||
| Latest Twelve Months | 14.5% | 14.2% | 10.5% | -1.1% | 4.6% | 8.4% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 11.2% | 12.1% | 23.1% | 18.4% | 15.3% | 13.0% | ||
| Prior Fiscal Year | 11.2% | 10.9% | 23.3% | 15.1% | 14.2% | 15.6% | ||
| Latest Fiscal Year | 10.8% | 11.5% | 23.8% | 15.8% | 31.8% | 2.8% | ||
| Latest Twelve Months | 11.5% | 12.4% | 24.8% | 15.8% | 31.8% | 9.7% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 12.4x | 17.0x | 17.1x | 6.3x | 21.4x | 10.1x | ||
| Price / LTM Sales | 3.4x | 4.0x | 6.4x | 1.9x | 5.3x | 2.0x | ||
| LTM P/E Ratio | 29.3x | 32.0x | 25.9x | 11.7x | 16.6x | 21.0x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/S Ratio | 1.9x | 4.0x | 6.4x | |||||
| Historical LTM P/S Ratio | 2.5x | 3.1x | 4.1x | |||||
| Selected Price / Sales Multiple | 2.6x | 2.7x | 2.9x | |||||
| (x) LTM Sales | 993,334 | 993,334 | 993,334 | |||||
| (=) Equity Value | 2,566,249 | 2,701,315 | 2,836,380 | |||||
| (/) Shares Outstanding | 1,127.8 | 1,127.8 | 1,127.8 | |||||
| Implied Value Range | 2,275.53 | 2,395.29 | 2,515.06 | |||||
| FX Rate: JPY/USD | 143.2 | 143.2 | 143.2 | Market Price | ||||
| Implied Value Range (Trading Cur) | 15.89 | 16.73 | 17.56 | 10.98 | ||||
| Upside / (Downside) | 44.7% | 52.4% | 60.0% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | 6869 | 4543 | 7741 | 1066 | ABT_KZ | OCPN.F | |
| Value of Common Equity | 1,695,246 | 4,001,457 | 5,374,234 | 24,285 | 182,104 | 1,773,067 | |
| (/) Shares Outstanding | 623.6 | 1,474.9 | 342.7 | 4,566.6 | 1,734.3 | 1,127.8 | |
| Implied Stock Price | 2,718.50 | 2,713.00 | 15,680.00 | 5.32 | 105.00 | 1,572.20 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 0.94 | 1.00 | 143.19 | |
| Implied Stock Price (Trading Cur) | 2,718.50 | 2,713.00 | 15,680.00 | 5.64 | 105.00 | 10.98 | |
| Trading Currency | JPY | JPY | JPY | HKD | USD | USD | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 0.94 | 1.00 | 143.19 | |